Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Familial risk of hidradenitis suppurativa

Key clinical point: Nearly half of patients with hidradenitis suppurativa (HS) reported having a first-degree relative affected by the condition.

Major finding: 57.5% of patients reported HS in either first- or second-degree relatives, including 49.5% who had an affected first-degree relative.

Study details: Analysis of detailed family history data from 676 HS patients collected using questionnaires.

Disclosures: The study was funded by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health. Fellowship Funding was provided by the Howard Holderness Foundation Medical Fellowship. Additional funding was provided by the University of North Carolina School of Medicine. CJ sayed reported relationships with various pharmaceutical companies.

Citation:

Bruinsma RL et al. Br J Dermatol. 2020 Nov 5. doi: 10.1111/bjd.19664.